⌘K

Login Start Free

Home/Filings/4/0001628280-22-024218

4//SEC Filing

Huber Reid M 4

Accession 0001628280-22-024218

CIK 0001358403other

View on SEC.gov Company Profile

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 10:29 AM ET

Size

4.9 KB

Accession

0001628280-22-024218

Insider Transaction Report

Form 4

Period: 2022-09-01

BELLICUM PHARMACEUTICALS, INCBLCM

Director

Transactions

Exercise/Conversion
Common Stock
2022-09-01+46,489→ 65,983 total

Footnotes (1)

[F1]The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date.

Documents

1 file

4
wf-form4_166212897072850.xmlPrimary
FORM 4

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1

filerCIK 0001607052

Filing Metadata

Form type: 4
Filed: Sep 1, 8:00 PM ET
Accepted: Sep 2, 10:29 AM ET
Size: 4.9 KB

View on SEC.gov